Spanish Consumer Durables Stock News

BME:MRL
BME:MRLREITs

A Look At MERLIN Properties SOCIMI (BME:MRL) Valuation After Strong 2025 Results And Data Center Momentum

MERLIN Properties SOCIMI (BME:MRL) has put its 2025 earnings firmly in focus for investors, highlighting full year sales of €538.96 million and net income of €786.13 million, supported by asset revaluations and low leverage. See our latest analysis for MERLIN Properties SOCIMI. The share price is now at €14.13 after a 12.95% 1 month share price return and a 14.60% year to date share price return. The 1 year total shareholder return of 45.35% and 5 year total shareholder return of 98.22% point...
BME:BBVA
BME:BBVABanks

Do BBVA's New US$2.5 Billion Notes Clarify Its Long-Term Funding Strategy (BME:BBVA)?

In late February 2026, Banco Bilbao Vizcaya Argentaria, S.A. completed and announced several US$-denominated senior non-preferred note offerings totaling US$2.50 billion, spanning fixed and floating-rate Eurobond and Eurodollar issues maturing in 2029 and 2036. These issuances, coming soon after BBVA reported record 2025 profit on strong loan growth and efficiency gains, highlight how the bank is tapping bond markets to support its balance sheet and funding mix. We’ll now examine how...
BME:IDR
BME:IDRIT

Indra Sistemas I‑485 C V2X Launch Tests Valuation And Growth Expectations

Indra Sistemas (BME:IDR) has launched its advanced Open Road Tolling system on the I-485 Express Lanes in North Carolina. The system combines tolling and C-V2X safety features and is now operational following a ribbon-cutting event. The project uses 3D LiDAR and connected vehicle technology for real-time traffic and safety management on a major U.S. corridor. For Indra Sistemas, a technology and mobility solutions provider, the I-485 project in North Carolina puts its Open Road Tolling and...
BME:SAN
BME:SANBanks

Banco Santander Board Refresh Links TSB Takeover To Growth And Dividends

Banco Santander (BME:SAN) has moved to reshape its leadership following the takeover of TSB Bank. Nicola Bannister is set to lead TSB after the acquisition, subject to final approvals. Deborah Vieitas has been proposed as a new independent director, adding international board experience. For investors watching Banco Santander at a share price of €10.268, these leadership moves come after a reported 67.0% return over the past year and a 3 year gain of 191.7%. The 5 year return of 288.7%...
BME:REP
BME:REPOil and Gas

Repsol (BME:REP) Valuation Check After 2025 Results And Higher 2026 Dividend Outlook

Repsol (BME:REP) is back in focus after releasing its full year 2025 results, combining lower reported sales with higher net income, a higher dividend guidance for 2026, and fresh production targets. See our latest analysis for Repsol. Repsol’s recent earnings, higher 2026 dividend guidance and updated production targets have come alongside strong momentum, with a 1 month share price return of 21.29% and a 1 year total shareholder return of 74.80%, while the 3 year total shareholder return...
BME:TEF
BME:TEFTelecom

Telefónica Expands UK Fibre And Modernizes Spain Operations After Recent Losses

Telefónica, through its nexfibre joint venture, announced the acquisition of UK fibre provider Substantial Group, aiming to expand fibre infrastructure in the UK. Telefónica Spain is adopting Red Hat OpenShift to modernize and unify IT and network functions across its operations. The company, listed as BME:TEF, last closed at €3.724. For investors watching BME:TEF, these moves come as the stock trades at €3.724, with a 9.0% return over the past 30 days and a 7.0% return year to date. The...
BME:NTGY
BME:NTGYGas Utilities

How Investors Are Reacting To Naturgy Energy Group (BME:NTGY) Earnings Growth Outpacing Modest Sales Increase

Naturgy Energy Group, S.A. has released its full-year 2025 results, reporting sales of €19,455 million and net income of €2,023 million, both higher than the prior year. This combination of slightly higher revenue and improved profitability highlights Naturgy’s ability to lift earnings even with relatively stable topline performance. We’ll now examine how this increase in full-year sales and net income could influence Naturgy’s existing investment narrative and risk balance. The future of...
BME:GRF
BME:GRFBiotechs

How Stronger 2025 Profitability At Grifols (BME:GRF) Has Changed Its Investment Story

Grifols, S.A. recently reported its full-year 2025 results, with sales rising to €7,524 million and net income reaching €402 million, lifting basic and diluted EPS from continuing operations to €0.59. The earnings release highlighted stronger profitability alongside revenue growth, suggesting that improved operations and product mix, including plasma-derived therapies, are becoming increasingly important to the business profile. We’ll now examine how this combination of higher revenue and...
BME:A3M
BME:A3MMedia

Assessing Atresmedia (BME:A3M) Valuation After Advertising Weakness And Expansion Beyond Traditional TV

Why Atresmedia’s latest results matter for shareholders Atresmedia Corporación de Medios de Comunicación (BME:A3M) has reported its 2025 results, highlighting revenue pressure from a weaker television advertising market, as well as record shareholder returns and a push into new media formats. See our latest analysis for Atresmedia Corporación de Medios de Comunicación. Atresmedia’s latest update comes after a mixed year in the market, with a 1-day share price return of 2.17% and a year to...
BME:COL
BME:COLOffice REITs

A Look At Colonial SFL Socimi S. A (BME:COL) Valuation After Rental Growth, Disposals, Buyback And Dividend News

Colonial SFL Socimi S. A (BME:COL) has drawn attention after reporting higher gross rental income and occupancy, completing property disposals that reduced its loan to value ratio, and announcing both a share buyback and dividend proposal. See our latest analysis for Colonial SFL Socimi S. A. Those full year results and capital actions sit alongside a 1 month share price return of 9.4% and a 90 day gain of 8.47%, while the 3 year total shareholder return of a 3.6% decline suggests longer term...
BME:PSG
BME:PSGCommercial Services

Assessing Prosegur (BME:PSG) Valuation After Strong 2025 Earnings And Dividend Increase

Prosegur Compañía de Seguridad (BME:PSG) has just released its full year 2025 results, reporting sales of €4,930.33m and net income of €119.32m, along with plans to increase its dividend. See our latest analysis for Prosegur Compañía de Seguridad. The earnings announcement and dividend increase come after a stronger run in the share price, with a 1-day share price return of 4.32% and a year to date share price return of 12.43%. Total shareholder return over the past year is 56.14%, suggesting...
BME:ANE
BME:ANERenewable Energy

Did Acciona Energía’s 2025 Profit Jump Despite Lower Sales Just Shift Corporación Acciona Energías Renovables' (BME:ANE) Investment Narrative?

Corporación Acciona Energías Renovables, S.A. reported its full-year 2025 results on February 26, 2026, with sales of €2,925 million versus €3,048 million a year earlier, while net income rose to €655 million and basic earnings per share from continuing operations increased to €2 from €1.1. The combination of lower sales but much higher net income and earnings per share highlights a sharp improvement in underlying profitability and cost efficiency during 2025. With net income rising strongly...
BME:ACX
BME:ACXMetals and Mining

Acerinox (BME:ACX) Valuation Check After 2025 Sales Growth And Shift To Net Loss

Acerinox (BME:ACX) has drawn attention after reporting full year 2025 earnings, with sales of €5.78b, operating cash flow of €455m and a net loss of €40.07m replacing the prior year’s profit. See our latest analysis for Acerinox. The earnings update has come alongside a 1 month share price return of 8.15% and a 90 day gain of 10.99%, while the 1 year total shareholder return of 24.81% and 5 year total shareholder return of 78.83% suggest momentum has been building over time despite the recent...
BME:PHM
BME:PHMBiotechs

Assessing Pharma Mar (BME:PHM) Valuation After Zepzelca Milestones And EBITDA Surge

Pharma Mar (BME:PHM) drew investor attention after its 2025 earnings call, where management highlighted a 27% revenue increase and a fivefold rise in EBITDA, largely tied to Zepzelca related milestones. See our latest analysis for Pharma Mar. The 1 day share price return of 1.52% to €80.25 comes after a steady 90 day share price return of 6.64%. However, the 1 year total shareholder return of a 15.4% decline shows recent enthusiasm has not fully reversed earlier weakness. If the Pharma Mar...
BME:GRF
BME:GRFBiotechs

Grifols Revenue Growth And Fibrinogen Launch Shape Evolving Investment Story

Grifols reported a solid revenue increase in 2025. The company improved free cash flow during the year. Grifols launched a new fibrinogen concentrate in Europe. A U.S. launch of the fibrinogen product is planned, pending FDA approval. For investors tracking Grifols (BME:GRF), the latest update combines financial progress with product news. The shares most recently traded at €10.63, with a 1% gain over the past year and a 45.4% decline over five years, highlighting how sentiment has shifted...
BME:REP
BME:REPOil and Gas

Is Repsol (BME:REP) Still Attractively Priced After Strong Multi Year Share Price Gains

If you are wondering whether Repsol’s current share price reflects its real worth, you are not alone. Many investors are asking the same question. Repsol’s share price recently closed at €19.02, with returns of 3.9% over 7 days, 17.0% over 30 days, 15.9% year to date, 63.5% over 1 year, 46.2% over 3 years, and 121.7% over 5 years. This puts recent performance firmly on the radar for valuation focused investors. Recent headlines around Repsol have focused on its positioning in the energy...
BME:ANA
BME:ANAElectric Utilities

Assessing Acciona (BME:ANA) Valuation After Strong 2025 Earnings And Share Price Rally

Acciona (BME:ANA) is in focus after reporting full year 2025 results, with sales of €20,236 million, revenue of €22,441 million, and net income of €803 million compared with €422 million a year earlier. See our latest analysis for Acciona. The earnings release and news of Acciona’s role in Madrid’s largest public EV charging project have coincided with a sharp shift in sentiment, with a 36.6% 1 month share price return and a 113.7% 1 year total shareholder return suggesting strong recent...
BME:SAN
BME:SANBanks

Is It Too Late To Consider Santander (BME:SAN) After Its Strong Multi Year Rally?

If you are wondering whether Banco Santander's current share price offers value or is starting to look stretched, you are not alone. This article is here to unpack that question clearly. The stock recently closed at €10.79, with returns of 0.3% over 7 days, 1.8% over 30 days, 5.2% year to date and 77.7% over 1 year. The 3 year and 5 year returns of 211.4% and 318.6% indicate very large gains over those periods. Recent coverage of Banco Santander has focused on its position among European...
BME:RED
BME:REDElectric Utilities

A Look At Redeia Corporación’s Valuation After Earnings Growth Investments And Hispasat Sale

Redeia Corporación (BME:RED) is back in focus after reporting full year 2025 earnings, with higher sales and net income, record investment in its transmission network, and extra balance sheet flexibility from the Hispasat sale. See our latest analysis for Redeia Corporación. At a share price of €15.73, Redeia Corporación has a 1 month share price return of 8.33% and a 5 year total shareholder return of 42.01%. This suggests that momentum has been supported by the latest earnings, record grid...
BME:TRE
BME:TREEnergy Services

Is Técnicas Reunidas (BME:TRE) Still Attractive After Its 140% One Year Rally?

If you are wondering whether Técnicas Reunidas is still attractively priced after its recent run, you are not alone. This article is aimed squarely at that question. The stock most recently closed at €36.96, with returns of 5.0% over 7 days, 19.2% over 30 days, 30.8% year to date, 139.7% over 1 year and 253.5% over 3 years, which may affect how you think about its current risk and reward balance. Alongside these moves, investors have been reacting to ongoing project activity and contract...
BME:VIS
BME:VISFood

Viscofan (BME:VIS) Valuation Check After Record 2025 Results And New Beat´30 Growth Plan

Viscofan (BME:VIS) is back on investors’ radar after reporting record 2025 revenue, EBITDA and profit, pairing those results with higher proposed shareholder payouts and a new Beat´30 plan aimed at longer term value creation. See our latest analysis for Viscofan. The recent earnings release, record 2025 results and the new Beat´30 plan seem to be feeding into improving momentum, with a 30 day share price return of 5.89% and a 90 day share price return of 10.63%, while the 5 year total...
BME:IBE
BME:IBEElectric Utilities

Iberdrola (BME:IBE) Valuation Check After Higher 2025 Net Income And Expanded Network Investments

Iberdrola (BME:IBE) just released its 2025 results, reporting sales of €45,546.8 million and net income of €6,285 million, supported by its networks business, revenue contribution from the UK and lower net debt. See our latest analysis for Iberdrola. The 2025 results land after a steady run in the market, with the latest share price at €20.05 and a 1 year total shareholder return of 48.35% that builds on a 5 year total shareholder return of 134.18%. If this earnings update has you thinking...
BME:FER
BME:FERConstruction

Ferrovial (BME:FER) Valuation Check After Recent Share Price Strength And Consensus Target Gap

Recent performance snapshot Ferrovial (BME:FER) has drawn investor attention after a recent move in its share price, with the stock last closing at €63.16 and delivering a 0.6% return over the past day. That short term gain sits alongside returns of 2.3% over the past week and about 11% over the past month, prompting some investors to reassess how the company’s current valuation lines up with its recent financial profile. See our latest analysis for Ferrovial. Looking beyond the recent move,...
BME:AMS
BME:AMSHospitality

Amadeus IT Group (BME:AMS) Valuation Check After Earnings And Revenue Beat

Amadeus IT Group (BME:AMS) recently reported quarterly results that beat analyst expectations on both earnings and revenue, which is a key catalyst for the stock’s latest move and a fresh data point for investors. See our latest analysis for Amadeus IT Group. Even after the latest earnings beat, Amadeus IT Group’s share price at €52.74 is still reflecting a 90 day share price return decline of 16.74% and a 1 year total shareholder return decline of 26.24%. The recent 1 day and 7 day share...